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Abstract
Chronic obstructive pulmonary disease (COPD)
is now a major public health concern; deaths
attributable to COPD in Latin America have in-
creased by 65.0% in the last decade. This study
was aimed at evaluating COPD prevalence and
associated factors in adults (≥ 40 years) living in
Greater Metropolitan São Paulo, Brazil. The
study is part of the Proyecto Latinoamericano
de Investigación en Obstrucción Pulmonar
(The PLATINO Project), a multi-center survey
on COPD burden in Latin America, with São
Paulo as the first center where the project has
been carried out. A population-based sample
was selected in multiple stages. Spirometry tests
were performed in each subject pre- and post-
bronchodilator and COPD was mainly defined
as the ratio of forced expiratory volume to forced
vital capacity below 70.0% (fixed ratio defini-
tion). Other spirometric criteria were also used
for the diagnosis of COPD. COPD prevalence
was 15.8% (95%CI: 13.5-18.1) using the fixed ra-
tio definition. COPD was positively associated
with age and smoking and inversely with body
mass index. Utilization of different COPD
spirometry criteria resulted in different percent-
ages of COPD, but similar associated factors.
Chronic Obstructive Pulmonary Disease; Risk
Factors; Tobacco; Pollution; Spirometry
Introduction
With the recent epidemiological transition in
Brazil, chronic diseases, including chronic ob-
structive pulmonary disease (COPD), now oc-
cupy the leading positions in morbidity and
mortality in the country. According to govern-
ment sources 1, one-fourth of all hospitaliza-
tions for respiratory problems in adults are due
to COPD. Analyzing mortality data, COPD ranks
first among causes of mortality due to respira-
tory diseases in adults (Ministério da Saúde.
Informações de Saúde On-line. http://www.
datasus.gov.br, accessed on 10/Aug/2004).
COPD is thus an important public health
problem, not only because of its high morbidi-
ty and mortality, but also because it is a pre-
ventable disease in many cases. For example,
cessation of smoking – the main risk factor for
COPD – could prevent millions of cases. Unfor-
tunately, the natural history of COPD is pro-
gressive and irreversible after a certain amount
of damage occurs to the lungs, in which case
treatment can only relieve the symptoms. It is
well known that the rate of lung function loss
can be reduced if smoking is stopped, and
smoking cessation is the only measure that can
improve survival.
COPD is still poorly understood by a large
proportion of physicians and unknown to the
population at large. Knowledge on COPD must
be increased such that the majority of health
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professionals can recognize the disease and
treat patients while there is still a chance of im-
proving their quality of life and preventing lung
function impairment.
There is considerable discussion about the
best diagnostic criteria for this disease. Al-
though there is agreement that spirometry is
the main diagnostic key, there is no consensus
as to the best spirometric criterion. A fixed ra-
tio of forced expiratory volume in one second
(FEV1)/forced vital capacity (FVC) below 70.0% 1
can be considered a good indicator for the dis-
ease, since it is easy and does not require refer-
ence values for each population. However this
criterion is quite sensitive and produces a cer-
tain number of false positives. On the other
hand, the GOLD criterion (Global Initiative for
Chronic Obstructive Lung Disease. Global Strat-
egy for the Diagnosis, Management, and Pre-
vention of Chronic Obstructive Pulmonary Dis-
ease. http://www.goldcopd.com, accessed on
10/Aug/2004) is very specific and provides a
unique opportunity to evaluate severity of COPD.
Unfortunately, it depends on reference values,
and such information is not always available.
This paper is not intended to discuss the
best criterion for diagnosing COPD. Rather, it
describes COPD prevalence according to the
fixed ratio functional criterion and the vari-
ables associated with it.
Materials and methods
A population-based cross-sectional study was
conducted in Greater Metropolitan São Paulo
during the first semester of 2003. São Paulo was
the first site included in the Proyecto Lati-
noamericano de Investigación en Obstrucción
Pulmonar (PLATINO Project), a multi-center
survey on COPD in major cities of Latin Ameri-
ca. Details of the multi-center study methodol-
ogy are described elsewhere 2. São Paulo is the
largest metropolitan area in Brazil, with a pop-
ulation of 17.8 million, located at 23 degrees
South, with an altitude of 760m (Demographic
and Geographic Data of the World Cities. http://
www.infoplease.com, accessed on 10/Aug/2004).
The sample was selected in multiple stages.
First, all census tracts in the city and metropol-
itan area were listed and sorted by socioeco-
nomic status. Then, 68 tracts were selected fol-
lowing a systematic protocol, which guaran-
teed stratification by socioeconomic status and
tract size proportional probability. In each
sampled tract, all households were listed and
the total count was updated; the ratio between
the expected number of households and the
actual count was used to calculate the number
of households to be sampled from that tract.
On average, 15 households were expected to be
selected from each tract, but this number was
greater for tracts where the number of house-
holds had increased since the previous census,
and smaller for tracts where it had declined.
Households were then systematically selected
from the updated listings. All adults aged 40
years or more living in the selected households
were included in the study.
The sample size obtained (n = 963) allowed
us to estimate a COPD prevalence of 15.0% with
a 2.5% margin of error. We were also able to de-
tect prevalence ratios of 1.75 or greater with a
power greater than 80.0% and confidence level
of 95% for exposures with frequency between
25.0% and 75.0%. These calculations consid-
ered sample clustering and additional for non-
response and multivariate analysis.
Each subject was submitted to spirometry
before and after bronchodilator use. Although
there are several spirometric criteria available
to define COPD (Table 1), we opted to use the
fixed ratio (FR) criterion, which considers COPD
as a ratio of FEV1/FVC below 70.0% 1, indepen-
dently of reference values for each population.
Several symptoms and clinical diagnoses of
pulmonary diseases were also investigated.
The questionnaire included sections from
the following instruments: American Thoracic
Society-Division of Lung Diseases (ATS/DLD) 3,
ECRHS II (European Community Respiratory
Survey II. http://ecrhs.org/quests.htm, ac-
cessed on 10/Aug/2004), Lung Health Study
(Lung Health Study Questionnaire. http://www.
bccrc.ca/downloads/ci/lc02_questionnaire.do
c, accessed on 10/Aug/2004). A copy of the
questionnaire is available upon request. Height
was measured with a portable Seca stadiome-
ter (precision 0.1cm), using the Lohman tech-
nique 4. A portable, battery-operated, ultra-
sound transit-time based spirometer (Easy-One
from NDD, Switzerland) was used. Calibration
was checked daily. Subjects performed up to 15
forced expiratory maneuvers to obtain three
ATS acceptable maneuvers, with FVC and FEV1
reproducible to 150ml. A bronchodilator (salbu-
tamol 200mcg) was then administered and the
test was repeated 15 minutes later. All spiro-
metric examinations were carried out with the
subject seated, wearing a nose clip and a dis-
posable mouthpiece.
Spirometry quality was evaluated and most
tests (over 90.0%) achieved ATS criteria of qual-
ity 5. The quality control results were fed back
to each fieldworker weekly, and the latter were
retrained if needed.
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The exclusion criteria for the study were
mental disease and institutionalization (less
than 3.0%). Spirometry was not performed in
subjects who reported, in the previous three
months, thoracic or abdominal surgery, my-
ocardial infarction, eye surgery (or detached
retina), hospitalization for any cardiac prob-
lem, current treatment for tuberculosis, or
pregnancy. The fieldworker took each subject’s
pulse before the exam, and those with heart
rates over 120 beats/minute were excluded.
There were 16 exclusions in this phase of the
study.
Analyses used the Stata program taking in-
to account the sampling design with the svy set
of commands. Anthropometric data were not
entered in the main analyses (multivariate),
due to a high likelihood of reverse causality.
Ethical approval was obtained from the In-
stitutional Review Board/Research Ethics Com-
mittee of the Escola Paulista de Medicina. The
results of spirometric tests were mailed to each
subject, and those with abnormal results were
offered free consultation at a hospital or reha-
bilitation center. Written informed consent was
obtained from each participant.
Results
Within the 1,113 households sampled, there
were 1,150 individuals eligible for the study; of
these, 963 performed spirometry. The overall
non-response rate was 15.3%, taking into ac-
count both household and individual contact
failures and refusals (including refusals only
for spirometry). Therefore, analyses of COPD
were carried out using 963 data points, al-
though analyses of associated factors used a
maximum of 1,000 individuals. Non-respon-
dents were similar to respondents in terms of
age and smoking status, but women responded
more than men (90.0% and 83.4%, respectively).
A description of the sample in terms of the
demographic and socioeconomic independent
variables is presented in Table 1. As expected,
due to the longer life expectancy, there were
more women than men in our sample. Mean
age was 55.2 years (SD = 11.3). Most subjects
classified themselves as white, followed by
mixed-race and black. Indigenous Brazilians
and Asians were rare. Approximately one in six
reported a family history (parents, siblings, or
children) of COPD, chronic bronchitis, or em-
physema. Average schooling was 5.9 years (SD =
4.9). We also asked about the father’s schooling;
approximately one-fourth were unable to in-
form their fathers’ level of schooling, while
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about one-half reported that their fathers had
never attended school.
Table 2 shows the description of the sample
in terms of behavioral, anthropometric, and
environmental variables. Nearly one-fourth
(24.0%) were smokers, and an additional third
(33.1%) were former smokers, while 42.9% had
never smoked. Current smokers accounted for
30.2% of the men and 19.0% of the women.
When 10.0% of the sample was re-interviewed
for quality control, the Kappa statistic for
smoking was 0.95, showing a high degree of re-
peatability. Lifetime exposure to active smok-
ing was also assessed; 19.0% of all subjects in-
formed having smoked more than 10 pack-
years. Prevalence of reported passive smoking
in the subject’s home in the previous two weeks
was 30.1%.
Table 1
Sample description according to demographic and socioeconomic variables. 
São Paulo, Brazil, 2003.
Variable %
Gender (n = 1,000)
Male 44.2
Female 55.8










Family history of COPD, bronchitis, or emphysema (n = 999)
No 14.7
Yes 85.3





Father’s schooling (n = 1,000)
None 46.6
Some 26.2
Do not know 27.2
COPD = chronic obstructive pulmonary disease.
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Nearly half of the sample (45.1%) presented
waist circumference values above the proposed
cut-off (88cm for females and 102cm for
males). Overweight and obese subjects (body
mass index: BMI ≥ 25kg/m2) comprised almost
two-thirds of the sample (62.7%). Prevalence
was 58.1% for men and 66.3% for women. Only
2.9% of all subjects reported any hospital ad-
mission due to respiratory disease during child-
hood. Exposure to dust in the workplace for 10
years or more was reported by 33.7% (Table 2).
We used several spirometric, symptom-
based, and clinical diagnostic criteria to esti-
mate COPD prevalence. As expected, these dif-
ferent criteria resulted in a wide range of preva-
lence. However, variance among spirometry
criteria was smaller than the differences in com-
parison to symptom-based and clinical diag-
noses. Table 1 describes all criteria used to esti-
mate COPD prevalence in this study, with re-
spective definitions and prevalence in our
sample. The FR criterion resulted in the high-
est COPD prevalence, while the GOLD criteri-
on resulted in the lowest value.
Four sources of domestic smoke were stud-
ied: coal was used for cooking by 14.4% of all
subjects and for heating by 1.7%; the corre-
sponding exposures to biomass (mainly wood)
were 47.5% and 6.4%. Due to the low frequency
of exposure to heating fuels, these variables were
classified in two groups: exposure to coal and
exposure to domestic biomass fuels (Table 3).
Table 4 shows the analysis of demographic
and socioeconomic factors associated with
COPD. Men were 32.0% more likely than women
to have COPD, but the difference was not sig-
nificant (p = 0.06). Individuals aged 60 or over
were three times more likely to have COPD
than those aged 40-49 years. There were no sig-
nificant associations with skin color. There was
no association between family history of bron-
chitis, emphysema, or COPD and spirometric
results. Subjects with up to two years of formal
education were 1.5 times more likely to have
COPD as those with nine or more years of
schooling, but the difference was not signifi-
cant (p = 0.14).
Table 5 presents the same results for behav-
ioral and environmental factors. Smoking was
also strongly associated with COPD. Former
smokers had 23.0% greater risk, and current
smokers showed an increase of 104.0%. Hospi-
tal admissions due to respiratory disease did
not show any association with COPD. Reported
exposure to dust in the workplace for 10 years
or more was associated with a 36.0% increase
in the risk of COPD, but the difference failed to
reach significance (p = 0.08). Exposure to coal
Table 2
Sample description according to behavioral, anthropometric, and environmental
variables. São Paulo, Brazil, 2003.
Variable %




Lifetime cigarettes smoked (n = 989)
Never smoked 43.4*
≤ 1 pack-years 16.4
1.1-10 pack-years 20.9
> 10 pack-years 19.3
Passive smoking (n = 998)
No 69.9
Yes 30.1
Hospital admission due respiratory disease 
during childhood (n = 999)
No 97.1
Yes 2.9
Lifetime exposure to dust at workplace (n = 998)
Never 43.0
1-9 years 23.9
≥ 10 years 33.1
Exposure to coal stove for cooking or heating (n = 999)
No 85.0
Yes 15.0
Exposure to biomass stove for cooking or heating (n = 998)
No 50.9
Yes 49.1
Waist circumference (n = 996)
Below cut-off 54.9
Above cut-off (≥ 88cm for females or ≥ 102 for males) 45.1





* The difference in the number of missing values explains why 
the percentage of non-smokers is slightly different from the percentage 
of subjects with no lifetime exposure.
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smoke in the home also increased the preva-
lence of COPD by 40.0%, while exposure to do-
mestic biomass smoke was not associated with
the outcome.
We also addressed the relationship between
spirometric results and anthropometry. Sub-
jects with waist circumference above the pro-
posed cut-off points (88cm for females and
102cm for males) showed significantly lower
forced expiratory volume (FEV1) (p < 0.001) than
those with normal waist circumference. While
mean FEV1 was 2.73 (SD = 0.77) for subjects be-
low the cut-off point, it was 2.37 (SD = 0.77) for
those above. The same trend was observed for
forced vital capacity (FVC), with means of 3.65
(SD = 0.90) and 3.18 (SD = 0.94) for subjects be-
low and above the cut-off points, respectively
(p < 0.001). Significantly higher results (p = 0.04)
for the FEV1/FVC ratio were found among sub-
jects above the cut-off point compared with
those below. However, when waist circumfer-
ence was treated as a continuous variable, no
significant associations were found with FEV1,
FVC, or FEV1/FVC, indicating possible non-lin-
earity (data not shown in tables).
The association between BMI and COPD
was also evaluated. The frequencies of COPD
were 50.0%, 17.5%, 13.9%, and 13.2% among
undernourished, normal-BMI, overweight, and
obese, respectively (p < 0.001) (data not shown
in tables).
All analyses were repeated using the GOLD
II-IV definition, and the results were mainly
unchanged, except for the fact that p values
tended to be higher due to the lower frequency
of COPD using the GOLD definition (data not
shown).
Discussion
The literature is scarce on COPD prevalence
and associated factors in Latin America. There
are few population-based studies, and most of
these have been conducted in selected samples.
COPD is projected to rank fifth in 2020 in
terms of worldwide burden of disease 3. More-
over, COPD is still not recognized as a major
public health problem in either developed or
developing countries.
The study presented here was an initiative
of the Asociación Latinoamericana del Tórax
(ALAT) to fill the knowledge gap on this disease
in Latin America. It is a multi-center study with
five sites (PLATINO Project). São Paulo was
chosen as the site in Brazil, and the results
shown in this paper relate only to São Paulo.
We wish to emphasize some epidemiologi-
cal aspects of this study. The survey resulted in
a representative sample of a large metropolitan
area with a high response rate. For example, ac-
cording to the DATASUS database from the
Table 3
Spirometric, symptom-based, and clinical diagnoses of chronic obstructive pulmonary disease (COPD) 
in the PLATINO study with respective definitions and prevalence. São Paulo, Brazil, 2003.
Variable Definition* Prevalence
Spirometric criteria
Fixed Ratio FEV1/FVC < 70.0% (where FEV1 is forced expiratory volume in the first second, 15.8%
and FVC is forced vital capacity)
GOLD II-IV** FEV1/FVC < 70.0% and FEV1 < 80.0% of predicted value 6.0%
ATS*** FEV1/FVC below 5th percentile and FEV1 < 100.0% of predicted value 11.3%
ERS# FEV1/FVC < 88.0% of predicted value for men and < 89.0% for women 14.2%
Symptomatic criteria
Chronic bronchitis Cough with phlegm for at least 3 months per year in previous 2 years 3.1%
Emphysema Breathlessness due to exercise 36.9%
Clinical diagnoses
COPD Reported lifetime diagnosis of COPD 0.8%
Chronic bronchitis Reported lifetime diagnosis of chronic bronchitis 3.9%
Emphysema Reported lifetime diagnosis of emphysema 1.2%
* For the analyses of lung function measurements, the NHANES Mexican-American reference values were used 7;
** Global Obstructive Lung Disease (http://www.goldcopd.com);
*** American Thoracic Society 13;
# European Respiratory Society 14.
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Unified National Health System (http://www.
datasus.gov.br), 44.1% of subjects aged 40 years
or more living in Greater Metropolitan São
Paulo are males; in our sample, the equivalent
proportion was 44.2%. Standardization and
rigorous quality control procedures ensured
that data quality was appropriate (see details
on the study’s quality control) 2. Reliance on
post-bronchodilator spirometry as the key di-
agnostic method for COPD and the use of mul-
tiple diagnostic indices allowed us to compare
this study’s results with those from previously
published surveys. As the main diagnostic tool
for COPD in this study, we had to be certain of
the quality control in the spirometry. Accord-
ing to ATS criteria (three acceptable measure-
ments with FVC and FEV1 reproducible to
200ml), 87.0% of the pre- and 95.0% of the post-
bronchodilator tests met these recommenda-
tions; this shows the good reproducibility of
spirometry during this study.
COPD prevalence according to the FR crite-
rion found in this study and compared with an-
other study conducted in southern Brazil 6
shows similar prevalence (15.8% and 15.2%, re-
spectively). Although spirometry was performed
in a sub-sample in the latter study, the results
appear similar and reinforce the specificity of
the GOLD criterion as compared to FR, since in
both studies the prevalence of COPD by the
GOLD criterion was lower. The adoption of FR
as the main outcome in the PLATINO Project
was due to the absence of reference values for
classifying individuals as having COPD in some
sites within this multi-center study. For other
criteria such as GOLD, it is necessary to com-
pare lung function measurements obtained
from the study population with reference val-
Table 4
Prevalence of chronic obstructive pulmonary disease (COPD) according to demographic and socioeconomic variables, 
with respective prevalence ratios (PR), 95.0% confidence intervals (CI), and significance tests. São Paulo, Brazil, 2003.
Variable COPD (%) Crude analysis Adjusted analysis
PR (95%CI) P-value PR (95%CI) p-value
Gender* 0.09** 0.06**
Male 18.0 1.29 (0.96-1.73) 1.32 (0.99-1.76)
Female 14.0 1.00 1.00
Age in years*** < 0.001# < 0.001#
40-49 8.4 1.00 1.00
50-59 16.2 1.94 (1.40-2.69) 1.94 (1.40-2.67)
≥ 60 25.7 3.08 (2.22-4.27) 3.11 (2.24-4.31)
Skin color/Ethnicity## 0.4** 0.6**
White 16.2 1.00 1.00
Mixed-race 12.8 0.79 (0.55-1.15) 0.87 (0.61-1.25)
Black 18.6 1.15 (0.74-1.77) 1.21 (0.79-1.87)
Indigenous 21.7 1.34 (0.60-3.01) 1.32 (0.60-2.86)
Asian 22.7 1.40 (0.61-3.23) 1.35 (0.65-2.80)
Family history of COPD, bronchitis, or emphysema## 0.9** 0.9**
No 15.7 1.00 1.00
Yes 16.3 1.04 (0.65-1.66) 1.05 (0.66-1.66)
Schooling (years of formal education)## 0.003# 0.14#
0-2 22.1 2.13 (1.28-3.55) 1.51 (0.91-2.50)
3-4 16.3 1.58 (0.97-2.57) 1.20 (0.73-1.97)
5-8 14.4 1.39 (0.80-2.43) 1.27 (0.73-2.20)
≥ 9 10.4 1.00 1.00
* Adjustment for age;
** Wald test for heterogeneity;
*** Adjustment for gender;
# Wald test for trend;
## Adjustment for gender and age.
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ues from another population or from the same
population. Some countries in Latin America
lack their own reference curves, and the project
thus used the NHANES reference values 7.
COPD prevalence in São Paulo was similar
to that found by Celli et al. 1 (16.0%) using the
FR criterion for analysis of NHANES data (indi-
viduals > 30 years). Review of the literature
shows a wide variability in COPD prevalence
according to different diagnostic criteria. This
has been described by other authors 1,8,9, em-
phasizing how much such criteria can affect in-
ternational prevalence comparisons.
When the PLATINO Project was designed,
another multi-center survey was planned in
countries outside of Latin America (BOLD Pro-
ject). Investigators from the two projects decid-
ed to use the same methodology, thus allowing
future comparisons on prevalence and factors
associated with COPD among several countries.
COPD can be under-diagnosed by physi-
cians, with this range varying from 0.8% for
COPD to 1.2% for emphysema and 3.9% for
chronic bronchitis. If physicians fail to recog-
nize this disease, patients cannot be treated,
nor can the disease be prevented. It is urgent to
increase COPD awareness among physicians in
order to help thousands of people who suffer
from this disease.
Regarding factors associated with COPD, it
is well known that the main risk factor is smok-
ing. Despite major efforts in Brazil to reduce
smoking, according to our study nearly one-
fourth of the adult population in São Paulo are
current smokers and 33.1% are former smok-
ers. Another worrisome finding is that more
than half of this Brazilian sample are over-
weight or obese. Using our data on smoking
prevalence (23.9%) and the adjusted relative
risk for COPD among smokers (2.04 for the FR
criterion and 2.57 for GOLD II-IV), it was pos-
sible to quantify the etiological fraction of
smoking on COPD prevalence using the follow-
ing formula:
Table 5
Prevalence of chronic obstructive pulmonary disease (COPD) according to behavioral and environmental variables, 
with respective prevalence ratios (PR), 95% confidence intervals (95%CI), and significance tests. São Paulo, Brazil, 2003.
Variable COPD (%) Crude analysis Adjusted analysis
PR (95%CI) p-value PR (95%CI) p-value
Hospital admission for respiratory disease 0.8** 0.7**
during childhood*
No 15.9 1.00 1.00
Yes 13.8 0.87 (0.34-2.22) 1.18 (0.49-2.89)
Lifetime exposure to dust at workplace*** 0.02# 0.08#
Never 13.7 1.00 1.00
1-9 years 13.0 0.95 (0.60-1.49) 1.04 (0.66-1.64)
≥ 10 years 20.8 1.52 (1.09-2.12) 1.36 (0.96-1.93)
Exposure to biomass stove for cooking or heating* 0.8** 0.4**
No 15.5 1.00 1.00
Yes 16.2 1.04 (0.78-1.40) 0.88 (0.66-1.17)
Exposure to coal stove for heating or cooking## 0.03** 0.08**
No 14.7 1.00 1.00
Yes 22.1 1.50 (1.05-2.14) 1.40 (0.96-2.03)
Smoking status* 0.003# < 0.001#
Never smoked 12.5 1.00 1.00
Former smoker 15.5 1.24 (0.87-1.74) 1.23 (0.88-1.72)
Current smoker 21.9 1.76 (1.23-2.52) 2.04 (1.41-2.95)
* Adjustment for gender, age, schooling, lifetime exposure to dust at workplace, and exposure to coal stove for heating or cooking;
** Wald test for heterogeneity;
*** Adjustment for gender, age, schooling, and exposure to coal stove for heating or cooking;
# Wald test for trend;
## Adjustment for gender, age, schooling, and lifetime exposure to dust at workplace.
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exposure frequency x 
etiological fraction =
(relative risk - 1)
1 + exposure frequency x 
(relative risk - 1)
Using this formula, the attributable fraction
of current smoking was 17.9% according to the
FR criterion and 26.2% with GOLD II-IV. There-
fore, smoking control would prevent one out of
four to five COPD cases.
Dust exposure at the workplace was related
to increased risk of COPD in the crude analy-
sis, but the result did not remain significant af-
ter adjusting for gender, age, schooling, and
coal exposure. Although non-significant, the
adjusted prevalence ratio of 1.36 cannot be ig-
nored in terms of public health. The same was
true for coal exposure, which showed a crude
prevalence ratio of 1.50 (p = 0.03), but decreased
to 1.40 (p = 0.08) after adjustment for gender,
age, schooling, and dust exposure at the work-
place. The negative relationship between COPD
and BMI is consistent with the literature 10,11.
Two possible limitations of our study
should be noted. The first is that some subjects
diagnosed as COPD may be asthmatics. Even
using post-bronchodilator FEV1/FVC < 70.0%,
it is impossible to rule out some misclassifica-
tion. The second limitation is that sample size
calculations for analysis of associated factors
were initially carried out in order to use the
pooled database (using all sites in the multi-
center study). Thus, some relevant associations
were not detected as significant in this study,
such as male gender, coal exposure, and life-
time dust exposure at the workplace, possibly
due to the sample size.
To the best of our knowledge, this is the first
Brazilian population-based study on COPD
prevalence and associated factors based on
spirometric results, including over 800 individ-
uals. By showing a strong positive association
between COPD and age, our data reinforce the
need for closer attention to this health prob-
lem, since the Brazilian elderly population is
growing 12, and COPD may be one of the lead-
ing causes of morbidity and mortality among
these subjects in the near future.
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Resumo
A doença pulmonar obstrutiva crônica (DPOC) é hoje
um grande desafio para a saúde pública; as mortes
atribuídas a DPOC na América Latina aumentaram
65,0% na última década. Avaliou-se a prevalência de
DPOC e fatores associados em uma população adulta
(≥ 40 anos) da grande área metropolitana de São
Paulo, Brasil. Esse estudo faz parte do Proyecto Lati-
noamericano de Investigación en Obstrucción Pul-
monar (Projeto PLATINO), um estudo multicêntrico
sobre DPOC em grandes cidades da América Latina,
tendo sido São Paulo o primeiro centro onde o projeto
se realizou. O estudo foi transversal de base popula-
cional e amostragem em múltiplos estágios. Os indiví-
duos realizaram espirometria, e DPOC foi basicamente
definida como a razão entre o volume expiratório
forçado em um segundo (VEF1) e a capacidade vital
forçada (CVF) abaixo de 70,0% (relação fixa). Outros
critérios espirométricos foram também utilizados
para o diagnóstico de DPOC. A prevalência de DPOC
foi de 15,8% (IC95%: 13,5-18,1) usando-se o critério
mencionado acima. DPOC associou-se positivamente
com idade e tabagismo e inversamente com o índice
de massa corporal. O uso de diferentes critérios es-
pirométricos acarretou mudanças na freqüência de
DPOC, mas não nos fatores associados.
Doença Pulmonar Obstrutiva Crônica; Fatores de
Risco; Tabaco; Poluição; Espirometria
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